Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 2 960.05 INR 0.49% Market Closed
Market Cap: 369.7B INR
Have any thoughts about
Ajanta Pharma Ltd?
Write Note

Gross Margin
Ajanta Pharma Ltd

75.8%
Current
74%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
75.8%
=
Gross Profit
34B
/
Revenue
44.9B

Gross Margin Across Competitors

Country IN
Market Cap 369.7B INR
Gross Margin
76%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 710.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.5B USD
Gross Margin
69%
Country US
Market Cap 251.1B USD
Gross Margin
77%
Country CH
Market Cap 202.7B CHF
Gross Margin
73%
Country CH
Market Cap 183.3B CHF
Gross Margin
75%
Country UK
Market Cap 162.4B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%
No Stocks Found

Ajanta Pharma Ltd
Glance View

Market Cap
369.7B INR
Industry
Pharmaceuticals

Ajanta Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 7,234 full-time employees. The company went IPO on 2000-06-05. The Company’s marketing network operates in domestic and international markets. The firm produces a comprehensive range of specialty products targeting different therapeutic segments for the treatment of patients, customized to each market it is present in. The branded generics business is spread in India and approximately 30 emerging countries across Africa, South-East Asia, West Asia, and The Commonwealth of Independent States (CIS). The company has product portfolio includes complex technology products. The firm has also made substantial investments in its research and development (R&D) facilities.

AJANTPHARM Intrinsic Value
1 831.68 INR
Overvaluation 38%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
75.8%
=
Gross Profit
34B
/
Revenue
44.9B
What is the Gross Margin of Ajanta Pharma Ltd?

Based on Ajanta Pharma Ltd's most recent financial statements, the company has Gross Margin of 75.8%.